Group 1: Company Overview and Product Capacity - The company produces various products with capacities as follows: Special Polyether 19,000 tons/year, Polyether Amine 31,000 tons/year, Alkyl Glycoside 35,000 tons/year, Flame Retardants 34,800 tons/year, Silicone Oil 4,600 tons/year, and Silicone Rubber 8,500 tons/year [2] - The current capacity utilization rate is good, and the company is focused on capturing market opportunities to secure more orders [2] Group 2: Dividend Policy and Historical Performance - Since its listing in 2017, the company has distributed a total of 308 million RMB in dividends, with the total funds raised at 264 million RMB [3] - The dividend payout ratios from 2016 to 2023 have shown a consistent increase: 18%, 19%, 19%, 24%, 44%, 48%, 59%, and 63% respectively [3] - For the 2024 profit distribution, the company plans to distribute 2.00 RMB (including tax) per 10 shares, totaling 43,001,596 RMB [3] Group 3: Share Buyback Plan - The share buyback will commence on May 13, 2025, and will last for 12 months [4] - The company will adhere to information disclosure requirements during the buyback period [4] Group 4: Market Trends and Future Outlook - In the surfactant sector, the company aims to strengthen its product line and enhance quality, maintaining deep cooperation with renowned companies [5] - The flame retardant business is expected to see a slight decline in scale due to oversupply in the domestic market [5] - The organic silicone rubber materials are projected to have a slight increase in gross profit due to leading technology and brand advantages [5] - The market trends for 2025 are expected to follow the development patterns observed in 2024 [5]

证券代码：300610 证券简称：晨化股份 公告编号：2025-039 扬州晨化新材料股份有限公司 关于首次回购公司股份的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 扬州晨化新材料股份有限公司（以下简称"公司"）于 2025 年 4 月 17 日 召开第四届董事会第十七次会议、第四届监事会第十七次会议，并于 2025 年 5 月 13 日召开 2024 年度股东会，审议通过了《关于回购公司股份方案的议案》， 同意公司使用自有资金或自筹资金以集中竞价交易方式回购公司普通股（A 股） 股票，本次回购的股份将全部用于注销并减少注册资本。本次回购股份的资金 总额不低于人民币 2,000 万元（含本数）不超过人民币 4,000 万元（含本数）， 回购股份价格不超过人民币 15.50 元/股（含）。本次实施期限自公司股东会审 议通过本次回购股份方案之日起 12 个月内。具体内容详见公司于 2025 年 4 月 18 日及 2025 年 5 月 16 日披露在巨潮资讯网（www.cninfo.com）的《关于回购 公司股份方案的公告》（公告编号：2025-032） ...

证券代码：300610 证券简称：晨化股份 公告编号：2025-040 企业名称：淮安晨化新材料有限公司 主要负责人：史永兵 单位地址：淮安工业园区实联大道15号 经济类型：有限责任公司(非自然人投资或控股的法人独资) 扬州晨化新材料股份有限公司 关于全资子公司换发安全生产许可证的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 扬州晨化新材料股份有限公司全资子公司淮安晨化新材料有限公司完成安 全生产许可证的换发工作，并收到江苏省应急管理厅颁发的《安全生产许可证》， 具体内容如下： 编号：（苏）WH安许证字[H00145] 统一社会信用代码：913208003211576747 特此公告。 扬州晨化新材料股份有限公司董事会 2025 年 5 月 22 日 许可范围:氨溶液[含氨>10%]（7000吨/年）*** 有效期:2025年5月18日至2028年5月17日 发证机关：江苏省应急管理厅 发证日期：2025年5月18日 ...

Group 1: Share Buyback and Financial Strategy - The company plans to implement a share buyback starting from May 13, 2025, for a period of 12 months, with disclosures to be made as per regulations [2] - The 2024 profit distribution plan includes a cash dividend of 2.00 CNY per 10 shares, totaling 43,001,596.00 CNY [4] - The company intends to use between 20 million and 40 million CNY for share repurchase, with all repurchased shares to be canceled [5] Group 2: Production and R&D Facilities - The company has one headquarters and two R&D bases located in Nanjing and Fuzhou, along with two production bases in Yangzhou and Huai'an [2] - The Huai'an facility is expanding its production capacity for alkyl glycosides by 35,000 tons per year, with plans to commence production in 2025 [3] Group 3: Market and Product Insights - The domestic market capacity for alkyl glycosides is estimated to be around 150,000 to 200,000 tons, with the largest application fields being pesticides and daily chemicals [3] - The consumption ratio of fatty alcohols in alkyl glycosides ranges from 19.5% to 23.5% [3] Group 4: M&A Strategy - The company is focusing on acquiring businesses with annual revenues between 100 million and 1.5 billion CNY, particularly in the biochemistry or electronic chemistry sectors [6] - The target net profit for potential acquisitions is between 30 million and 100 million CNY, with a preference for companies with at least two core technology products [6] Group 5: Future R&D Projects - The company is investing in the development of bio-based polyols, which have shown promising initial results and are expected to enhance profit margins [7] - Sales of polyether amines in specialized fields exceeded 1 million CNY in 2024 [7] - The promotion of alkyl glycosides in high-end cosmetics has resulted in sales of over 21 tons in 2024 [7]

Group 1 - China State Construction signed new contracts totaling 1.52 trillion yuan from January to April, representing a year-on-year increase of 2.8% [1] - Yongpu Medical's subsidiary obtained a medical device business license valid until May 7, 2030, allowing it to engage in medical device retail and wholesale [1] - Ningbo Maritime received a government subsidy of 4.42 million yuan, which will impact its net profit for the fiscal year 2025 [1] Group 2 - Mingpu Optoelectronics obtained a patent for a magnetic powder core and its preparation method, enhancing its capabilities in magnetic materials technology [1] - Digital Zhitong plans to establish a wholly-owned subsidiary in Beijing with a registered capital of 5 million yuan [1] - Zhongmin Energy's shareholder plans to reduce its stake by up to 0.28% of the company's total shares [1][6] Group 3 - Tunnel Holdings' controlling shareholder intends to increase its stake in the company by investing between 250 million to 500 million yuan [1] - China Telecom appointed Liu Guiqing as the new President and COO [1] - Datang Power completed the issuance of 3 billion yuan in medium-term notes, with proceeds aimed at repaying debt and supplementing working capital [1] Group 4 - *ST Weihai won a bid for a flood control project worth 182 million yuan, accounting for 7.35% of its audited revenue for 2024 [1] - Huijin Tong announced a cash dividend of 0.0868 yuan per share, totaling 29.44 million yuan [1] - Xinkai Energy's shareholders plan to reduce their holdings by a combined total of 4% of the company's shares [1][39] Group 5 - Xinhuan Group's subsidiary won a 1.02 billion yuan nuclear power project contract [1] - Southern Airlines reported a 12.14% year-on-year increase in passenger turnover for April [1] - Xinjiang Torch plans to acquire 100% equity of Yushan Litai for 125 million yuan [1]

证券代码：300610 证券简称：晨化股份 公告编号：2025-038 扬州晨化新材料股份有限公司 关于使用自有闲置资金进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 扬州晨化新材料股份有限公司（以下简称"晨化股份"或"公司"）于 2025 年 5 月 13 日召开 2024 年度股东会，会议审议通过了《关于使用自有闲置资金进行现金管理的议案》， 同意公司及子公司在确保不影响正常运营的情况下，使用不超过 120,000 万元自有闲置资金 进行现金管理，期限为自 2024 年度股东会审议通过之日起至 2025 年度股东会召开之日止。 公 司 董 事 会 、 监 事 会 出 具 的 决 议 刊 载 于 2025 年 4 月 18 日 巨 潮 资 讯 网 （http://www.cninfo.com.cn）。根据上述决议，近日公司及子公司使用自有闲置资金购买 了 5,000 万元的理财产品。现将具体情况公告如下： | 序 号 | 资金来 源 | 签约单位 | 产品名称 | 金额 (万 | 产品 | 产品 起息日 | | 产品 到期日 | | ...

证券代码：300610 证券简称：晨化股份 公告编号：2025-037 1、扬州晨化新材料股份有限公司(以下简称"公司")将使用自有资金或自筹 资金以集中竞价交易方式回购公司普通股（A股）股票（以下简称"本次回购"）， 本次回购的股份将全部用于注销并减少注册资本。本次回购资金总额不低于人民 币2,000万元（含本数）不超过人民币4,000万元（含本数），具体回购资金总额以 回购期满时实际回购股份使用的资金总额为准。回购股份价格不超过人民币15.50 元/股，按回购价格上限和回购总金额上下限计算，预计回购股份数量为1,290,323 股至2,580,645股，占公司目前总股本的0.60%至1.20%，具体回购股份的数量以回 购期满时实际回购的股份数量为准。本次实施期限自公司股东会审议通过本次回 购股份方案之日起12个月内。 2、本次回购股份方案已经公司第四届董事会第十七次会议、第四届监事会第 十七次会议、2024年度股东会审议通过。 3、公司已在中国证券登记结算有限责任公司深圳分公司开立了回购专用证券 账户。 4、相关风险提示 （1）本次回购股份方案存在因回购期限内公司股票价格持续超出回购价格上 限，进而导致本 ...

证券代码：300610 证券简称：晨化股份 公告编号：2025-036 扬州晨化新材料股份有限公司 2024 年度股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东会未出现否决议案的情形。 2、本次股东会未涉及变更以往股东会已通过的决议。 一、会议召开和出席情况 （一）会议召开情况 1、会议召开时间： 现场会议时间：2025 年 5 月 13 日（星期二）下午 14:30 网络投票时间：通过深圳证券交易所交易系统进行网络投票的具体时间为： 2025 年 5 月 13 日上午 9:15－9:25，9:30－11:30，下午 13:00－15:00；通过深 圳证券交易所互联网投票系统进行网络投票的具体时间为：2025 年 5 月 13 日上 午 9:15 至下午 15:00 期间的任意时间。 2、会议召开地点：江苏省宝应县淮江大道 999 号公司十一楼 1102 会议室 3、会议召开方式：现场表决和网络投票相结合的方式 4、会议召集人：公司董事会 5、会议主持人：董事长于子洲先生 6、本次会议的召集、召开和表决程序符合有关法律 ...

上海市锦天城律师事务所 关于扬州晨化新材料股份有限公司 2024 年度股东会的 法律意见书 地址：上海市浦东新区银城中路 501 号上海中心大厦 9/11/12 层 电话：021-20511000 传真：021-20511999 邮编：200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于扬州晨化新材料股份有限公司 2024 年度股东会的 法律意见书 致：扬州晨化新材料股份有限公司 上海市锦天城律师事务所（以下简称"本所"）接受扬州晨化新材料股份有 限公司（以下简称"公司"）委托，就公司召开 2024 年度股东会（以下简称"本 次股东会"）的有关事宜，根据《中华人民共和国公司法》（以下简称"《公司 法》"）、《上市公司股东会规则》等法律、法规、规章和其他规范性文件以及 《扬州晨化新材料股份有限公司章程》（以下简称"《公司章程》"）的有关规 定，出具本法律意见书。 为出具本法律意见书，本所及本所律师依据《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则（试行）》等规定，严格履行 了法定职责，遵循了勤勉尽责和诚实信用原则，对本次股东会所涉及的相关事项 进行了必要的核 ...

Group 1: Production Capacity and Methods - The company has an annual production capacity of 31,000 tons of polyether amine, with larger volume products typically produced using continuous processes, while smaller volume products are produced using batch processes [2]. - Since July of the previous year, the company has significantly adjusted its polyether amine shipment structure, increasing supply for non-wind power small variety products [2]. Group 2: Market Trends and Pricing - The price of polyether amine D230 has risen from 11,500 RMB/ton at the end of last year to 14,500 RMB/ton recently, indicating a recovery in the market [3]. - The price increase is attributed to a rational rebound after a previous price drop and a peak in wind power installation capacity due to policy influences [3]. Group 3: New Projects and Environmental Approvals - The company’s subsidiary, Huai'an Chenhua, is working on a project to produce 34,000 tons of polyurethane functional additives, which is pending environmental approval and aims for production in 2025 [4]. - Another project for expanding the production of alkyl glycosides to 35,000 tons is in the process of obtaining environmental impact assessment approval, with a target for production in 2025 [4]. Group 4: Financial Strategies and Shareholder Returns - The company plans to use between 20 million and 40 million RMB for a share buyback, pending approval at the 2024 annual shareholder meeting [5]. - A cash dividend of 2.00 RMB per 10 shares is proposed for the 2024 fiscal year, totaling approximately 43 million RMB [5]. - The company emphasizes the importance of using idle funds for short-term financial management to enhance returns for shareholders [6]. Group 5: Industry Position and Competitors - The company is recognized as an early and comprehensive producer of polyether amine in China, with nearly 30 different product models [2]. - Competitors in the alkyl glycosides market include the company and Chuanhua Zhili [4]. Group 6: Future Growth and M&A Strategy - The company aims to reserve 2-3 potential acquisition targets annually, striving to successfully acquire one each year to enhance its growth trajectory [6]. - The focus remains on integrating upstream and downstream operations while exploring investment opportunities in new materials, fine chemical additives, and biomanufacturing [6].